(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 4.77%459.38M | 45.52%1.76B | -18.99%438.45M | -48.02%1.21B | -61.14%541.25M | 76.85%2.33B | 118.46%1.39B | -44.32%1.32B | -48.51%637.5M | -45.65%2.37B |
Operating income | 4.77%459.38M | 45.52%1.76B | -18.99%438.45M | -48.02%1.21B | -61.14%541.25M | 76.85%2.33B | 118.46%1.39B | -44.32%1.32B | -48.51%637.5M | -45.65%2.37B |
Cost of sales | -56.33%-124.26M | -20.85%-258.44M | 4.47%-79.49M | 78.78%-213.85M | 88.58%-83.21M | -388.98%-1.01B | -473.45%-728.72M | 19.29%-206.06M | -84.45%-127.08M | 78.38%-255.3M |
Other costs | ---- | -18.34%-481.41M | ---- | 19.99%-406.81M | 10.88%-227.05M | -9.65%-508.42M | -10.73%-254.76M | 23.16%-463.68M | 25.87%-230.07M | 4.98%-603.43M |
Operating expenses | -56.33%-124.26M | -19.21%-739.86M | 74.38%-79.49M | 59.06%-620.66M | 68.45%-310.25M | -126.36%-1.52B | -175.37%-983.48M | 22.01%-669.74M | 5.83%-357.15M | 52.71%-858.73M |
Gross profit | -6.64%335.12M | 73.21%1.02B | 55.40%358.96M | -27.45%590.03M | -43.55%231M | 25.64%813.29M | 45.96%409.2M | -57.03%647.34M | -67.35%280.36M | -40.60%1.51B |
Selling expenses | -53.95%-22.87M | -89.39%-203.54M | 60.14%-14.85M | 47.23%-107.47M | 71.80%-37.26M | -58.13%-203.66M | -167.80%-132.14M | 55.66%-128.8M | 68.51%-49.34M | 31.84%-290.46M |
Administrative expenses | 8.47%-70.72M | 1.82%-282.67M | 48.72%-77.26M | 22.96%-287.91M | 22.54%-150.67M | 3.35%-373.72M | -7.27%-194.5M | 23.06%-386.66M | 17.68%-181.32M | 3.83%-502.57M |
Profit from asset sales | ---- | ---- | ---- | --212.07M | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus | -57.45%-730.86M | 26.94%-1.32B | 48.41%-464.18M | -269.10%-1.8B | -554.65%-899.7M | 59.62%-488.88M | 120.16%197.89M | 70.68%-1.21B | 24.40%-981.82M | -336.07%-4.13B |
-Changes in the fair value of investment property | -57.45%-730.86M | 26.94%-1.32B | 48.41%-464.18M | -269.10%-1.8B | -554.65%-899.7M | 59.62%-488.88M | 120.16%197.89M | 70.68%-1.21B | 24.40%-981.82M | -336.07%-4.13B |
Impairment and provision | -180.31%-356K | 89.97%-135K | 78.47%-127K | -46.15%-1.35M | 32.26%-590K | 36.04%-921K | -17,520.00%-871K | -598.27%-1.44M | -98.11%5K | 100.81%289K |
-Other impairment is provision | -180.31%-356K | 89.97%-135K | 78.47%-127K | -46.15%-1.35M | 32.26%-590K | 36.04%-921K | -17,520.00%-871K | -598.27%-1.44M | -98.11%5K | 100.81%289K |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | 6.37%-386.2M | ---- | 38.88%-412.48M | ---- | ---674.89M |
Special items of operating profit | -49.20%-152.01M | -94.79%-371.46M | -491.03%-101.89M | -27.90%-190.7M | -117.83%-17.24M | -131.59%-149.1M | -7.41%96.68M | 33.03%471.98M | -87.02%104.42M | -59.17%354.78M |
Operating profit | -114.36%-641.7M | 27.40%-1.15B | 65.77%-299.35M | -101.44%-1.59B | -332.41%-874.46M | 22.68%-789.19M | 145.46%376.25M | 72.68%-1.02B | -6,603.09%-827.7M | -189.58%-3.74B |
Financing cost | 11.41%-412.86M | -33.14%-919.18M | -112.10%-466.02M | ---690.39M | -13.58%-219.72M | ---- | 18.12%-193.45M | ---- | 30.89%-236.26M | ---- |
Share of profits of associates | ---- | 97.24%-344K | ---- | -1,448.13%-12.45M | ---- | 98.52%-804K | ---- | -183.04%-54.26M | ---- | 68.24%65.34M |
Share of profit from joint venture company | ---- | -91.23%-12.68M | ---- | 83.89%-6.63M | ---- | -60,417.65%-41.15M | ---- | 37.61%-68K | ---- | -51.39%-109K |
Earning before tax | -37.78%-1.05B | 9.26%-2.09B | 30.05%-765.37M | -176.63%-2.3B | -698.55%-1.09B | 22.68%-831.15M | 117.18%182.8M | 70.71%-1.07B | -200.38%-1.06B | -205.07%-3.67B |
Tax | 423.02%12.25M | -40.82%57.78M | -106.66%-3.79M | 6.71%97.64M | 834.75%56.93M | -55.30%91.5M | 272.62%6.09M | 61.02%204.69M | 95.88%-3.53M | 176.82%127.12M |
After-tax profit from continuing operations | -35.51%-1.04B | 7.86%-2.03B | 25.85%-769.16M | -197.66%-2.2B | -649.12%-1.04B | 15.01%-739.64M | 117.70%188.89M | 75.44%-870.29M | -142.68%-1.07B | -206.48%-3.54B |
After-tax profit from non-continuing business | -20,940.70%-2.52B | ---- | --12.09M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Earning after tax | -370.54%-3.56B | 7.86%-2.03B | 27.01%-757.07M | -197.66%-2.2B | -649.12%-1.04B | 15.01%-739.64M | 117.70%188.89M | 75.44%-870.29M | -142.68%-1.07B | -206.48%-3.54B |
Minority profit | -3,294.67%-97.73M | 130.35%18.09M | 103.79%3.06M | 77.95%-59.6M | -82.23%-80.82M | -162.85%-270.31M | 42.65%-44.35M | -201.82%-102.84M | -197.33%-77.33M | -47.25%101M |
Shareholders should account for profits from continuing business | -35.51%-1.04B | ---- | ---769.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Shareholders should account for profits from non-continuing business | -26,916.47%-2.42B | ---- | --9.03M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -355.79%-3.46B | 4.45%-2.05B | 20.53%-760.13M | -356.39%-2.14B | -510.06%-956.44M | 38.85%-469.33M | 123.56%233.24M | 78.94%-767.45M | -90.67%-990.16M | -216.20%-3.64B |
Basic earnings per share | -338.10%-0.92 | 3.45%-0.56 | 19.23%-0.21 | -346.15%-0.58 | -533.33%-0.26 | 38.10%-0.13 | -77.78%0.06 | 78.79%-0.21 | 292.86%0.27 | -216.47%-0.99 |
Diluted earnings per share | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data